immune system
• IL25 treatment induces more IL5 positive cells and fewer IFNG expressing cells
|
• in the bronchoalveolar lavage of mice after repeated challenge with allergens
|
• more cells in the bronchoalveolar lavage, predominantly eosinophils and CD4+ T cells, after repeated intranasal challenge with the Aspergillus oryzae protease and OVA allergens
|
• in cultured naive T cells after activation with anti-CD3 and anti CD28 in the presence of IL25
|
• in splenocytes, lung cells and draining lymph node cells after repeated intranasal challenge with the Aspergillus oryzae protease and OVA allergens
|
• in cultured naive T cells after activation with anti-CD3 and anti CD28 in the presence of IL25
• in splenocytes, lung cells and draining lymph node cells after repeated intranasal challenge with the Aspergillus oryzae protease and OVA allergens, and OVA challenge ex vivo
|
• a strong induction of IL9 expression in T cells treated with IL25
|
• more cells in the bronchoalveolar lavage, predominantly eosinophils and CD4+ T cells, after repeated intranasal challenge with the Aspergillus oryzae protease and OVA allergens
|
respiratory system
• more cells in the bronchoalveolar lavage, predominantly eosinophils and CD4+ T cells, after repeated intranasal challenge with the Aspergillus oryzae protease and OVA allergens
|
hematopoietic system
N |
• naive mice have no defect in overall development of hematopoietic system
|
• IL25 treatment induces more IL5 positive cells and fewer IFNG expressing cells
|
• in the bronchoalveolar lavage of mice after repeated challenge with allergens
|